Johnson & Johnson takes the crown as the world’s largest drug and Biotech Company again
this year, edging out Pfizer and Swiss giant Novartis once again.
With $16.3 billion in profits, $131 billion in assets, and $276 billion in
market value, the American icon tops the list in 3 out of the
4 metrics that we use to determine the Global 2000 List of the world’s
largest public companies.
Pfizer holds onto
its No.2 spot this year thanks to its huge assets, while
Novartis trails just behind at the third place. Lower sales and
profits amid tough competition and the strong dollar have hurt the New
York-based drug maker’s overall ranking this year. Despite smaller assets
than Pfizer’s, Novartis remains the largest drug maker by revenue, profits and market
value, narrowing its gap to Pfizer.
The
FORBES Global 2000 is a comprehensive list of the world’s largest, most
powerful public companies, as measured by revenues, profits, assets and market
value. This year’s Global 2000 companies hail from 60 countries and account for
combined revenues of $39 trillion, profits of $3 trillion, with assets worth
$162 trillion, and a market value of $48 trillion.
This article is taken from - http://www.forbes.com/sites/liyanchen/2015/06/04/2015-global-2000-the-worlds-largest-drug-and-biotech-companies/ for information purpose only.
------------------------------------------------------------------------
Actually currently there are so many great biotech companies. Big or small, all have their own advantages. Do you think so?
ReplyDeleteYes! There are various parameters used by different people,surveys,studies and websites to rank a company in a particular field.
ReplyDeleteHere on BiotechBox we had discussed "The Biggest Biotech companies in the world according to Forbes List" in a race of making money or profit by using Biotechnology.